Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barbara Lopez Kunz currently holds 400 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Lopez Kunz has been a net buyer of APVO stock. They have purchased $8.5K and sold $0 worth of shares.
Barbara Lopez Kunz's most recent insider trade was on Aug 6, 2026, when they sold 400 shares at $0.00 per share.
Barbara Lopez Kunz serves as Executive at Aptevo Therapeutics Inc. (APVO). They have executed 11 insider transactions totaling $8.5K over their tenure at the company.
Barbara Lopez Kunz holds the position of Executive at Aptevo Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Barbara Lopez Kunz has shown a buying trading pattern, with $8.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Barbara Lopez Kunz was on Jun 10, 2019, when they purchased $8.5K worth of APVO shares. This transaction involved 10,000 shares at $0.85 per share.
Barbara Lopez Kunz currently owns 400 shares of Aptevo Therapeutics Inc. (APVO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barbara Lopez Kunz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barbara Lopez Kunz has 11 Form 4 filings on record as an insider at Aptevo Therapeutics Inc..
Set alerts for Barbara Lopez Kunz and 40,000+ other insiders.